Ain’t No Stoppin’ Us Now: Cervivor’s 2026 Cervical Cancer Summit Ignited Advocacy and Elevated Survivors

By Sara Lyle-Ingersoll, Cervivor Communications Director

On January 23, 2026—the day after the United States formally completed its withdrawal from the World Health Organization (WHO)—survivors, clinicians, advocates, researchers, and policy leaders gathered at the historic National Press Club in Washington, D.C. for the 2026 Cervical Cancer Summit Powered by Cervivor, Inc.

The timing was not lost on anyone in the room.

For decades, the WHO has played a central role in advancing global cervical cancer elimination. As the Summit began, speakers acknowledged the moment with clarity and resolve: Global collaboration still matters, science still matters, and the work does not stop.

As Ebony Hoskins, MD, gynecologic oncologist at MedStar Washington Hospital Center, said during her morning session, “That makes it even more important that we continue to use global standards for elimination and rely on organizations like Cervivor to get the word out and engage our community navigators.”

Mission accepted, Dr. Hoskins.

At the top of the agenda, Cervivor Ambassador and Cervivor Español Co-Lead Karla Chavez welcomed both in-person and virtual attendees with a heartfelt message from Siguatepeque, Honduras. Having previously shared her lived experience as part of the WHO’s Cervical Cancer Elimination Day of Action, her perspective carried particular significance.

In-person and virtual attendees turned their attention to a welcoming message from Cervivor Ambassador Karla Chavez, joining from her home country of Honduras.

If you were in the room, you could feel the momentum already building toward elimination. If you weren’t, here’s what you missed.

Cervivor’s Founder: “We Make the Data Come Alive”

The packed speaker slate began with Cervivor Founder and Chief Visionary Tamika Felder’s annual State of Cervical Cancer address, reflecting on the organization’s 21 years of impact—and the work still ahead. Taking the stage to the iconic 1979 anthem “Ain’t No Stoppin’ Us Now,” she wove together her personal journey as a young cervical cancer survivor, the evolution of Cervivor from a grassroots support network into a global advocacy organization, and the power of community to transform isolation into action.

Cervivor’s founder and 24-year cervical cancer survivor Tamika Felder kicked off the Summit with a powerful mandate for change.

“We make the data come alive,” Tamika reminded the audience. Survivor voices give meaning to the numbers and urgency to the mission.

She challenged attendees not only to absorb the information shared throughout the Summit, but to carry it forward into their communities, healthcare systems, and policy spaces—reminding the audience that the work doesn’t end when the Summit does. “Whatever we talk about today, let’s not leave it here at the National Press Club,” she urged. “Let’s make sure everyone is talking about cervical cancer.”

An Emphasis on Evidence

Several early sessions reinforced a critical truth: We already know how to prevent cervical cancer, but access, trust, and implementation are uneven. Distinguished speakers grounded their messages in data, making the point unmistakable.

Dr. Hoskins highlighted both advances and persistent gaps, including the reality that a significant number of cervical cancer diagnoses still occur later in life and among people who were told screening was no longer necessary.

Dr. Ebony Hoskins gave an in-depth presentation on cervical cancer advances and gaps.

Her message was direct and evidence-based: Cervical cancer screening saves lives, innovation matters, and patients must be empowered to actively engage in their care. Her advice to patients: “Bring your questions written down. Bring a support person to be a second set of ears. Anxiety can make it hard to process information and support matters.”

That emphasis on evidence continued with Silke Schoch, MA, of the National Health Council, who showed how patient experience mapping becomes more meaningful when patients themselves help shape it. Through a striking comparison, she contrasted a “before” dry, clinically driven journey map with an “after” redesigned version that was more accessible and genuinely useful to those navigating care. Schoch also credited the launch of a tool to help organizations, academic institutions, and nonprofits equitably compensate patients for their time and expertise, saying, “Patients are all experts, and they should be compensated as experts and treated as experts.”

Silke Schoch with the aforementioned revised patient experience map on the screen behind her.

Next, speaking directly to the many cervical cancer patients and survivors in the audience, research expert Irene Aninye, PhD, reframed the role of lived experience in advancing change. “You are a data point—but you are more than a statistic,” she said. “When your story is paired with the numbers, people remember. That’s how progress happens.” Through interactive polling, she led the audience in discussion about the importance of prioritization and coalition-building to compel policy and systems change.

“The data is in the room,” said Irene Aninye, referring to the lived experience of patients and survivors in attendance.

Later in the day, Michelle Fiscus, MD, FAAP, Chief Medical Officer of the Association of Immunization Managers, shed light on more solid evidence: HPV vaccination prevents cancer. Walking participants through the complex history of the HPV vaccine—with some levity along the way—she explained how what should have been a public health success story when it was introduced in 2006 instead became a breeding ground for misinformation and vaccine hesitancy. “We’ve been able to prevent cancer for 20 years,” she said, “and yet this vaccine became a firestorm almost from the moment it was introduced.”

Michelle Fiscus’s information-packed session paired evidence with wit.

She emphasized that strong, consistent recommendations remain essential. “The problem isn’t the science. It’s how unevenly it’s been implemented—and how easily trust can be undermined.”

From Awareness to Action

That call-to-action energy carried through every session at the century-old club. In a purposeful discussion on the impact of proclamations, Cervivor Ambassador Christy Basa Chambers captured the urgency felt across the room: “This should be called Cervical Cancer Action Month, not just Cervical Cancer Awareness Month,” she said.

Cervivor Ambassador Christy Basa Chambers joked she is the “self-proclaimed Proclamation Queen.”

A Cervivor Community Vision and Impact session demonstrated what is possible when survivors turn pain into purpose. Moderated by Cervivor Ambassador and Program Coordinator Lauren Lastauskas and featuring Cervivor Ambassadors Trish Byerly, Claudia Pérez-Favela, and Joslyn Chaiprasert-Paguio, the panel traced each speaker’s unique journey from diagnosis to advocacy—and how reclaiming one’s voice can break stigma, close equity gaps, and save lives locally, nationally, and globally.

During the Cervivor Community Vision and Impact panel, Cervivor Ambassador Joslyn Chaiprasert-Paguio (center) explained how she shares her story to ensure others get the information and support she did not.

Joslyn, who hosts the Cervivor Podcast, spoke about fertility loss, nearly losing her life during childbirth, and the realization that “you’re never really done with cancer,” adding, “That’s when I knew this had to be my path—to speak up for people who don’t always have that option.”

The session concluded with an emotional moment of recognition, when Trish presented Tamika with a flag flown in her honor—at the request of Senator Tim Kaine of Virginia—on the 74th anniversary of Henrietta Lacks’s passing, October 4, 2025.

Cervivor Ambassador Trish Byerly (right) reads from the flag’s dedication, honoring founder Tamika “in recognition of her unwavering commitment to ending cervical cancer” and for inspiring and empowering “women to find strength from within.”

Later, in a Community In Action session, moderated by Cervivor Ambassador Tiera Wade, panelists Adana Llanos, PhD, MPH (Columbia University), Brooke Stewart, MPH (Louisiana Cancer Prevention), and Paris Thomas, PhD, MS (Equal Hope), explored how community-rooted partnerships are critical to advancing equity. “Equity work requires sustainability,” Paris noted, reflecting her nuanced understanding of the Chicago communities she serves. “That means supporting the people doing the work so they can continue showing up without burning out.”

Brooke shared a powerful example from a recent partnership with Cervivor’s 2025 Communities of Color initiative in New Orleans, where HPV self-sampling was brought directly to a neighborhood parade and dozens of women were tested on the spot. “It was just beautiful,” she said.

Brooke Stewart (left) spoke about a successful community outreach collaboration with Cervivor in New Orleans this past November 2025.

Treating Patients as Stakeholders

Ahead of the Summit, keynote speaker Matthew Zachary, founder of Stupid Cancer and We the Patients and longtime Cervivor ally, reflected publicly on why the gathering mattered. In a LinkedIn post, he wrote:

“Cervical cancer exposes the system in plain sight. Prevention exists. Screening exists. Treatment exists. People still die because access collapses along lines everyone pretends not to see.”

Zachary carried that clarity into his highly anticipated session, speaking candidly about survivorship, power, and the role of organized patient voices in shaping systems change. He also read publicly for the first time from the acknowledgments and foreword of his upcoming book, We the Patients: Understanding, Navigating, and Surviving America’s Healthcare Nightmares, offering a deeply personal reflection on the influences that shaped his work—including his younger self, who survived brain cancer in his early twenties, and those who did not make it.

Making his first public book reading at the Summit, keynote speaker Matthew Zachary is also the host of the longest-running independent healthcare podcast, Out of Patients (formerly The Stupid Cancer Show).

Following, Cervivor Ambassador Kate Weissman slipped into glittery “teal heels” on stage before sharing her cervical cancer story and how it propelled her into legislative advocacy. Diagnosed at age 30, Kate detailed how an insurance denial forced her family to pay $100,000 out of pocket—an experience that later led her to become the lead plaintiff in a historic, multi-year class action lawsuit and policy changes that closed loopholes insurers used to deny care.

“You don’t have to be a policy expert to advocate,” she encouraged fellow survivors in the audience while demystifying lobbying. “You just need to show up, tell the truth about your experience, and connect it to why change is needed. Lawmakers remember stories. They remember faces.”

Cervivor Ambassador Kate Weissman asserted, “Survivors belong in legislative spaces,” grounding the message in her own patient advocacy journey.

Kate also announced a new Cervivor Survivor Policy and Advocacy Working Group she is spearheading to equip survivors with the tools, training, and support needed to engage lawmakers and advance policies that improve outcomes for patients and families. Sign up here.

During the following Advancing Patient Advocate Voices panel, moderated by Citseko Staples Miller of FTI Consulting, with Matthew, Kate, and Taylor Hosier, Director of Patient Navigation for the Ulman Foundation, the panelists examined how patient advocacy shapes cancer systems and why cross-sector collaboration is essential to lasting change. As Citseko emphasized, “Patients are not an afterthought—they are stakeholders.”

Virtual attendees, shown here on a laptop monitor during the Advancing Patient Advocate Voices panel, shared insightful and poignant perspectives during Q&A and other interactive moments through Team Cervivor’s moderators.

Holding Space for the Full Survivor Experience

The Summit made room for honesty—not just about prevention and policy, but about survivorship itself.

In a heart-centered session, motivational speaker Dr. Stephanie Broadnax Broussard, LCSW-S, APHSW-C, named what many survivors carry quietly: Grief exists alongside survival. Placing a hand over her chest, she reminded the room that grief “exists here,” within the body and the lived experience of being human: chronic pain, neuropathy, changes in identity, intimacy, fertility, and confidence in the future. Community, she said, doesn’t remove grief, but it can help carry it.

Dr. Stephanie Broadnax Broussard opened her session with characteristic humor, noting, “This isn’t a session where we won’t laugh—because I’m funny—but it may be a little heavier than you expected.”

That candor carried into Dr. Stephanie’s “Both/And Reality” exercise, inviting survivors and advocates to name two truths they were holding at the same time. The responses captured the complexity of the task in minimal words:

“Grateful and grieving.” – Yvette Torres, Cervivor Ambassador

“Healing and hurting.” – Carol Lacey, Lead Cervivor Ambassador

“Exhausted and resilient.” – Linda Eckert, ObGyn professor and book author

Linda Eckert, author of Enough: Because We Can Stop Cervical Cancer, was one of many engaged audience members at the Summit.

From there, Team Cervivor’s Christina Turpin led an interactive session reminding attendees that while this work is a marathon, the Summit itself was a sprint—an opportunity to capture momentum and turn it into action. Joining virtually, Cervivor community member Leanne offered a simple but resonant affirmation: “I am the positive ripple.”

The Summit’s final speaker was Beth Battaglino, RN-C, CEO of HealthyWomen, whose remarks cut directly to the heart of the moment. “We have the science, we have the tools—and yet,” she said, “every year in the U.S., more than 13,000 people are diagnosed with cervical cancer, and over 4,000 still lose their lives.”

HealthyWomen CEO Beth Battaglino encouraged attendees, “Your voice belongs in healthcare decisions.”

“The gap between what we know and what we do is where your voice matters,” Battaglino continued. Education, she reminded the audience, “doesn’t move on its own. Policy does not change on its own, and access doesn’t expand on its own. People move them forward.”

To close the Summit on a heartfelt note (well, several notes), Cervivor Ambassador and New York music teacher Yvette Torres took the stage to sing the room out with a live rendition of “We Are Cervivor,” a song she wrote and recorded to uplift the cervical cancer survivor community. 

Cervivor Ambassador Yvette Torres led the audience in singing, “We Are Cervivor.”

Our Heartfelt Thanks—And the Work Continues

To everyone who joined us in Washington, D.C., or followed along online, we offer our sincere gratitude for another successful Summit. A special thank you to our presenting sponsor, Hologic; partnering sponsor, Roche; supporting sponsor, Merck; and our valued in-kind partner, St. Jude HPV Cancer Prevention Program.

We are also deeply grateful to our exhibitors, who made the Summit even more enriching for attendees. We appreciate all that they brought (literally!) to the event: the National Foundation for Infectious Diseases (NFID), Ulman Foundation, Hopewell Cancer Support, ACHIEVE (The ACHIEVE Study), and KickIt Pajamas, co-founded by Cervivor Ambassador Cindy Trice. As always, we thank our dedicated volunteers who made this Summit possible.

But, as Cervivor’s founder Tamika reminded attendees at the outset, the work doesn’t end with the Summit. The 2026 Cervical Cancer Summit reaffirmed what Cervivor has known for 21 years: We have the data, lived experience, community, and a clear understanding of what works. Ending cervical cancer now requires sustained investment in prevention, survivor leadership, and community-rooted action.

Thank you to everyone whose participation and partnership made the 2026 Summit a success.

As Cervivor marks 21 years of impact, the Tell 21, Give 21 campaign supports survivor education, advocacy, research engagement, and prevention efforts. It saves lives every day.

We’re grateful to have already surpassed $30,000 toward our goal, and there is still more to do.

Tell your story.
Support the work.
Share the mission.

Together, we can continue building a future where cervical cancer is prevented—and survivors are heard. Save the date for the 2027 Summit!

All images courtesy of Portia Wiggins Photography.

About the Author

SARA LYLE-INGERSOLL is a seasoned content and communications expert dedicated to transforming lived experiences into impactful stories. Her award-winning magazine feature about a close friend who passed from cervical cancer in their twenties led her to connect with Cervivor’s founder, Tamika Felder, and solidified her commitment to cervical cancer awareness and prevention. Now, as Cervivor’s Communications Director, Sara brings this mission full circle.

Marking a Milestone: Q&A on the First World Cervical Cancer Elimination Day

Is it really possible to eliminate cervical cancer—not just reduce it or manage it, but wipe it off the map for good? The World Health Organization (WHO) says yes, and has set ambitious global targets to get there by 2030.

The WHO’s 90‑70‑90 cervical cancer elimination strategy calls for:

  • 90% of girls vaccinated against HPV by age 15
  • 70% of women screened by age 35 and again at 45
  • 90% of those diagnosed receiving timely treatment

But meeting this deadline will take more than aspiration—it will take collective action. And today is a major step forward.

November 17, 2025, is the first-ever World Cervical Cancer Elimination Day, designated earlier this year by the World Health Assembly. Think of it like World AIDS Day or World Polio Day—global observances that didn’t just raise awareness, but helped spark the vaccines, screenings, and policies that pushed those diseases to the brink of eradication.

Cervivor, Inc. Founder and Chief Visionary Tamika Felder and Nigeria’s First Lady and healthcare pioneer, Dr. Zainab Shinkafi-Bagudu, were among the leaders who advocated for the day’s creation, including co-authoring a global call to action via the World Economic Forum to support it and elevate its importance on the world stage.

“I started Cervivor 20 years ago to support those affected by cervical cancer, hoping one day it wouldn’t be needed,” Tamika reflected at the time. “But too many communities are still suffering and dying from this preventable disease. A global day of recognition sends a powerful message: Awareness isn’t enough—the time for education, action, and elimination is now.”

Tamika delivers her annual “State of Cervical Cancer” address at the 2025 Cervical Cancer Summit—rallying survivors, advocates, and health leaders toward a future free from cervical cancer.

Below, we bring you an exclusive Q&A with Tamika and Dr. Bagudu, who is also Founder and CEO of the Medicaid Cancer Foundation and President-elect of the Union for International Cancer Control (UICC), answering the same questions from Maryland, USA, and Kebbi State, Nigeria, respectively. Their voices—one from the frontlines of African health equity and the other from the heart of patient advocacy—remind us: Elimination isn’t a solo act. It’s a chorus.

Q: Why does World Cervical Cancer Elimination Day matter?

Tamika: As a cervical cancer survivor, this day feels deeply personal. It represents something I once couldn’t imagine: hope for a world where no one else has to hear the words “you have cervical cancer.” When the World Health Organization declared that eliminating cervical cancer is within reach, it turned our fight from awareness into action.

For survivors, this first official World Cervical Cancer Elimination Day is a milestone that honors every story, every loss, and every victory along the way. It reminds us that our voices matter and that lived experience can guide smarter policies, stronger outreach, and more compassionate care.

Dr. Bagudu: World Cervical Cancer Elimination Day is symbolic—a rallying point for action. The WHO’s declaration that elimination is within reach shows this is an achievable reality if we commit to the right strategies.

  • Globally, it unites countries around a common goal: HPV vaccination, wider screening, and timely treatment. As President-elect of the UICC, I see this observance as a vital tool to keep cervical cancer high on the agenda, especially for low- and middle-income countries.
  • Nationally in Nigeria, it validates years of advocacy by First Ladies Against Cancer (FLAC), which I co-founded. The FLAC Screening Clinic in Kebbi is one example of how global commitments can translate into local action.
  • Personally, it is deeply meaningful. As a physician, mother, and advocate, I have seen both the devastation of late diagnosis and the hope that comes with early screening or HPV vaccination.

Ultimately, this day transforms aspiration into accountability. It tells the world: We can, and we must, eliminate this disease in our lifetime.

Dr. Bagudu, presenting a diagram of the female reproductive system to women in a rural community in Kuje, Abuja, aims to empower people in her country—and around the world—with life-saving information on cervical cancer prevention and the importance of early screening.

Q: How can a global day like this drive real change?

Tamika: We’ve seen the power of global observances before. Days like World AIDS Day and World Polio Day didn’t just raise awareness; they mobilized action, funding, and accountability. World Cervical Cancer Elimination Day can do the same.

In the United States, it can shine a light on the inequities that persist in prevention and care while inspiring innovation and collaboration. When survivors, clinicians, policymakers, and advocates unite around a shared message, we can accelerate progress toward eliminating this preventable cancer.

Dr. Bagudu: Nigeria has made important strides. The government’s rollout of the HPV vaccination program is a landmark step, protecting millions of young girls. Screening services are also expanding, with initiatives like the FLAC Screening Clinic in Kebbi showing how early detection can be brought closer to communities.

Civil society has been central. Through First Ladies Against Cancer (FLAC), we’ve sustained awareness campaigns, mobilized resources, and ensured continuity of programs. Partnerships with groups like Roche and the Clinton Health Access Initiative have strengthened diagnostics and treatment pathways. And of course, the Medicaid Cancer Foundation is at the heart of it all.

Still, challenges remain. Many rural women face barriers of distance, cost, and stigma. Shortages of trained health workers delay follow-up and treatment. And while HPV vaccines are now part of the national program, consistent supply and uptake across all states will require sustained political will and funding.

For me, this progress proves that change is possible when government, civil society, and partners work together. But it also reminds us that elimination will not happen automatically—it demands accountability, innovation, and persistence.

Q: Why is cervical cancer elimination especially urgent in low-resource regions?

Tamika: The U.S. has the knowledge and tools to prevent nearly all cervical cancers, yet persistent inequities mean prevention isn’t reaching everyone. Communities of color, people in rural areas, immigrants, people without reliable insurance, and those with language or transportation barriers face higher risks and lower access to vaccination, screening, and timely treatment. As a survivor, I know how much access, awareness, and advocacy can determine outcomes.

Elimination in the U.S. must start with equity. That means expanding vaccination access in schools and clinics, funding community-led education, and supporting policies that make screening and treatment affordable and available for everyone. Until every community is reached, we have not truly achieved elimination.

At the recent Patient Advocacy Retreat for Communities of Color in New Orleans, Tamika Felder (far right) leads survivors and advocates in grassroots outreach—bringing life-saving cervical cancer education directly into underserved communities.

Dr. Bagudu: Cervical cancer is a stark example of global health inequity. While it is increasingly rare in high-income countries, including the U.S., it remains a leading cause of cancer deaths in Africa, where women are more likely to be diagnosed late, less likely to access treatment, and more likely to die from a preventable disease.

In Nigeria, the challenges are clear:

  • Access is uneven; urban women may find screening in tertiary hospitals, but rural women face long distances, high costs, and limited awareness.
  • Stigma and cultural barriers discourage care until symptoms are advanced.
  • Health system gaps include shortages of trained personnel, diagnostic tools, and reliable vaccine supply chains.

Yet there are real opportunities. The national HPV vaccination rollout can protect millions of girls. Screening is expanding through models like the FLAC Clinic in Kebbi, which shows how state leadership can drive change. Through the Medicaid Cancer Foundation and First Ladies Against Cancer, we’ve raised awareness, supported patients, and built partnerships that strengthen care.

As President-elect of UICC, I can amplify Africa’s voice globally, while at the grassroots, we continue training health workers and engaging communities. Cervical cancer elimination is urgent because every delay costs lives—but with political will, investment, and collaboration, it is achievable, and African women must not be left behind.

Q: What progress have you seen—and what gaps remain?

Dr. Bagudu: We are at a turning point. In Nigeria and across Africa, real progress has been made against cervical cancer.

The national HPV vaccination rollout is a landmark milestone, protecting millions of girls. Screening services are expanding, with clinics like the FLAC Screening Clinic in Kebbi, and awareness campaigns are beginning to shift cultural attitudes. Treatment capacity is also improving, with more cancer centers equipped for radiotherapy and chemotherapy, while education efforts keep cancer high on the agenda.

Still, the gaps are stark. Too many women are diagnosed late, rural and low-income communities face barriers of distance, cost, and stigma, and health systems struggle with workforce shortages, supply chain issues, and limited palliative care.

This is why innovation is critical. Self-collection for HPV testing, digital health tools, mobile outreach, and task-shifting to community health workers can expand access dramatically.

The Medicaid Cancer Foundation (MCF) is helping bridge these gaps by running awareness campaigns, supporting screening in urban and rural areas, providing financial and psychosocial support through our PACE program, and advocating for sustainable funding and best practices. Beyond Nigeria, we collaborate with regional and global partners to strengthen advocacy and ensure Africa’s challenges are reflected in international strategies.

In short, progress is real, but urgency remains. With innovation, collaboration, and sustained commitment, we can close the gaps and move decisively toward eliminating cervical cancer across the continent.

Dr. Bagudu speaks at the just-concluded Medicaid Cancer Foundation disbursement of roughly $70,000 to cancer patients in Abuja, highlighting the Foundation’s commitment to patient-centered care and financial support.

Tamika: From where I stand, what’s changing most is momentum. More people are learning that HPV causes cervical cancer, vaccination rates are improving in some regions, and new technologies like HPV self-collection are showing incredible promise. Survivors are stepping into leadership roles and helping shape the national conversation about prevention and equity.

But there is still work to do. Too many people remain unaware of their risk or lack access to timely screening and treatment. Stigma and fear continue to silence conversations about cervical health. Organizations like Cervivor are helping bridge those gaps by elevating survivor voices, promoting education, and partnering with health systems to ensure innovations reach those who need them most.

Q: What message would you share on this inaugural day?

Tamika: A future without HPV-related cancers looks like prevention in every community, equity in every policy, and hope in every story. It looks like the next generation growing up protected and informed. A world without cervical cancer means no more stories like mine—and that’s the legacy I want to leave behind.

Elimination is possible, but it will take continued investment, accountability, and survivor leadership. Those of us who have lived through cervical cancer know what’s at stake, and we’re committed to making sure no one else has to.

This collage features Cervivor community members from the U.S. and around the world, showcasing powerful patient advocacy and demonstrating what survivor leadership looks like in the fight to eliminate cervical cancer.

Dr. Bagudu: On this inaugural World Cervical Cancer Elimination Day, my message is one of hope and urgency. Hope—because for the first time, we have the tools to end a cancer. Urgency—because every year of delay costs thousands of women’s lives, especially in Africa.

A future without HPV-related cancers is one where girls are routinely vaccinated, women have access to simple, affordable screening close to home, and treatment is available without stigma or financial hardship. It is a future where communities celebrate survivorship rather than mourn preventable loss.

To get there, governments must prioritize vaccination, screening, and treatment; global partners must ensure equitable access; and civil society—including the Medicaid Cancer Foundation—must continue raising awareness, supporting patients, and holding leaders accountable. Innovation, from self-collection for HPV testing to digital health tools, will also be key. 

If you found this blog post helpful, please share it with friends and family. Knowledge is power—and you may just save a life. Questions? Contact us at [email protected].